Feature

Does the Role of CDMO Need to Evolve?

In short: Yes, says Mat Minardi, Chief Scientific Officer at Sterling Pharma Solutions

Share

5 Key Takeaways

  • 1

    CDMOs help to drive pharmaceutical innovation.

  • 2

    Outsourcing models are challenged by geopolitical volatility.

  • 3

    Evolving partnerships with big pharma are becoming crucial.

  • 4

    The Extended Bench model allows flexible access to scientific expertise.

  • 5

    Talent competition is increasing due to specialized drug development needs.

Related Content

Vaccine Guidance Splits: Now What?

Liability remains low, coverage stable as clinicians navigate fractured federal guidance

Is Point-of-Care Hepatitis C Virus Testing Too Expensive?

RNA testing carries substantial cost burden for hospitals, study finds

  • January 14, 2026

  • 2 min
Medical Oddities: A Vaccine With a Foam Head?

A week of bold ideas: drinkable vaccines, unrealistic TV CPR, yoga-assisted detox, and meat-heavy math.